Evonik to assign defined roles to major German sites under new focus

Evonik will strengthen growth over the next three years by sharpening its focus on all its activities, according to a September 22, 2026 company release datelined Essen, Germany. The business portfolio will be set up according to roles, and specific tasks will be assigned to the major sites in Germany.

Key facts

Market context

Evonik is a large specialty chemicals producer, and its portfolio spans performance additives, silicas, amino acids for animal nutrition, and specialty intermediates used across coatings, cosmetics, pharmaceuticals, agriculture, and consumer goods. Demand for these products tends to follow end markets such as personal care formulation, automotive and construction coatings, tyres and rubber, and animal feed, each with its own cycle and quality requirements. When a major producer reorganises its footprint, the effects usually show up gradually: customers may face changes in qualification, supply sourcing, or technical service contacts, while competitors watch for shifts in capacity and product focus. Specialty chemical buyers typically respond by reviewing dual-sourcing options and confirming supply continuity, while investors look at how site specialisation affects cost structure and returns. Europe's chemical sector has been under pressure from energy costs and competition, which makes site-level decisions in Germany a relevant signal for regional supply planning.

Source: official release on corporate.evonik.com. Summary and context written by Market Krystal.